 |
|
COMMENTS AND OPINIONS
A Question of the Clinical Relevance of Determining Thrombomodulin Level While Receiving Anticoagulant Therapy—Reply
Marcus Lind, MD;
Kurt Boman, MD, PhD
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In reply
We are most thankful for the insightful comments by Nguyen et al. As mentioned, thrombomodulin levels are affected by inflammation and several clinical conditions1 and are confounders in our study.2 We have tried to adjust for inflammation by including high-sensitivity C-reactive protein (hsCRP) in our multivariate models. The inclusion of hsCRP did not affect the outcome of the study, and it is unlikely that the associations found for thrombomodulin would be explained by inflammatory processes alone. We had also adjusted for diabetes in one population of the study cohort without effect on the main results. There were no associations found between sTM and myocardial infarction or mortality. Furthermore, the findings of our study were not affected when we adjusted for the indication for warfarin treatment; patients with mechanical heart valves had the same risk for bleeding at a given thrombomodulin level . . . [Full Text of this Article]
AUTHOR INFORMATION
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
Thrombomodulin as a Marker for Bleeding Complications During Warfarin Treatment
Marcus Lind, Kurt Boman, Lars Johansson, Torbjörn K. Nilsson, Ann-Kristin Öhlin, Lisbeth Slunga Birgander, and Jan-Håkan Jansson
Arch Intern Med. 2009;169(13):1210-1215.
ABSTRACT
| FULL TEXT
RELATED LETTER
A Question of the Clinical Relevance of Determining Thrombomodulin Level While Receiving Anticoagulant Therapy
Chi Thi Nguyen, Gar Ming Chan, and Mark Su
Arch Intern Med. 2009;169(21):2031.
EXTRACT
| FULL TEXT
|
